2/12
01:03 am
brtx
BioRestorative prices $5M stock offering [Seeking Alpha]
High
Report
BioRestorative prices $5M stock offering [Seeking Alpha]
2/11
10:30 pm
brtx
BioRestorative Announces Pricing of $5.0 Million Public Offering
High
Report
BioRestorative Announces Pricing of $5.0 Million Public Offering
2/11
07:30 am
brtx
BioRestorative Announces Positive Outcome from Type B Meeting with FDA
High
Report
BioRestorative Announces Positive Outcome from Type B Meeting with FDA
2/10
08:00 am
brtx
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease
High
Report
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease
2/1
09:11 pm
brtx
?????????????????????????????2035????18?6170??????49?5700???????????????(CAGR)10.29%???????????? [CNET News]
Low
Report
?????????????????????????????2035????18?6170??????49?5700???????????????(CAGR)10.29%???????????? [CNET News]
11/25
01:48 pm
brtx
Biorestorative Therapies (NASDAQ:BRTX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Biorestorative Therapies (NASDAQ:BRTX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
07:00 am
brtx
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease
Medium
Report
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease